Larvol Delta - First-patient-treated-with-Cu67-SARBombesin-in-theranostic-prostate-cancer-trial

Cu-67 SAR-Bombesin - Clarity Pharma

https://www.prnewswire.com/news-releases/first-patient-treated-with-cu-67-sar-bombesin-in-theranostic-prostate-cancer-trial-301945053.html

Oct 3, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next